Lantz Financial LLC Novartis Ag Transaction History

Lantz Financial LLC

  • $299 Million
  • Q1 2024

A detailed history of Lantz Financial LLC transactions in Novartis Ag stock. As of the latest transaction made, Lantz Financial LLC holds 7,194 shares of NVS stock, worth $777,887. This represents 0.23% of its overall portfolio holdings.

Number of Shares
7,194
Previous 7,459 3.55%
Holding current value
$777,887
Previous $753,000 7.7%
% of portfolio
0.23%
Previous 0.28%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 10, 2024
SELL
$95.27 - $108.47 $25,246 - $28,744
-265 Reduced 3.55%
7,194 $695,000
Q4 2023

Jan 12, 2024
BUY
$92.27 - $101.54 $830 - $913
9 Added 0.12%
7,459 $753,000
Q3 2023

Oct 20, 2023
BUY
$94.73 - $105.13 $2,652 - $2,943
28 Added 0.38%
7,450 $758,000
Q2 2023

Jul 12, 2023
SELL
$92.52 - $104.91 $35,527 - $40,285
-384 Reduced 4.92%
7,422 $748,000
Q1 2023

Apr 10, 2023
SELL
$80.03 - $92.81 $19,847 - $23,016
-248 Reduced 3.08%
7,806 $718,000
Q4 2022

Jan 23, 2023
SELL
$75.55 - $92.52 $3,701 - $4,533
-49 Reduced 0.6%
8,054 $0
Q3 2022

Oct 17, 2022
SELL
$74.61 - $87.26 $55,957 - $65,445
-750 Reduced 8.47%
8,103 $616,000
Q2 2022

Jul 29, 2022
SELL
$80.52 - $93.75 $11,192 - $13,031
-139 Reduced 1.55%
8,853 $748,000
Q1 2022

May 05, 2022
BUY
$80.11 - $90.62 $54,955 - $62,165
686 Added 8.26%
8,992 $789,000
Q4 2021

Jan 19, 2022
SELL
$79.7 - $88.13 $14,664 - $16,215
-184 Reduced 2.17%
8,306 $727,000
Q3 2021

Oct 14, 2021
BUY
$81.78 - $95.14 $32,957 - $38,341
403 Added 4.98%
8,490 $694,000
Q2 2021

Jul 16, 2021
SELL
$85.24 - $94.15 $7,330 - $8,096
-86 Reduced 1.05%
8,087 $738,000
Q1 2021

Apr 19, 2021
BUY
$83.5 - $98.47 $6,429 - $7,582
77 Added 0.95%
8,173 $699,000
Q4 2020

Jan 19, 2021
BUY
$78.07 - $94.43 $19,049 - $23,040
244 Added 3.11%
8,096 $765,000
Q3 2020

Oct 09, 2020
BUY
$82.14 - $91.0 $5,914 - $6,552
72 Added 0.93%
7,852 $683,000
Q2 2020

Jul 22, 2020
SELL
$80.93 - $91.1 $129,973 - $146,306
-1,606 Reduced 17.11%
7,780 $680,000
Q1 2020

Apr 10, 2020
BUY
$70.67 - $99.01 $72,860 - $102,079
1,031 Added 12.34%
9,386 $774,000
Q4 2019

Jan 17, 2020
SELL
$84.35 - $95.37 $45,970 - $51,976
-545 Reduced 6.12%
8,355 $791,000
Q3 2019

Oct 18, 2019
SELL
$85.54 - $94.26 $44,309 - $48,826
-518 Reduced 5.5%
8,900 $751,000
Q2 2019

Jul 15, 2019
SELL
$75.4 - $92.8 $13,496 - $16,611
-179 Reduced 1.87%
9,418 $867,000
Q1 2019

Apr 22, 2019
BUY
$75.32 - $86.15 $722,846 - $826,781
9,597 New
9,597 $923,000

Others Institutions Holding NVS

# of Institutions
1,350
Shares Held
140M
Call Options Held
1.15M
Put Options Held
866K
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $233B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Lantz Financial LLC Portfolio

Follow Lantz Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lantz Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lantz Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email